The purpose of screening is early diagnosis and treatment. Screening tests are usually administered to people without current symptoms, but who may be at high risk for certain diseases or conditions.
The same tests used to diagnose sickle cell disease can be used to screen for it before symptoms begin. These tests include:
Hemoglobin Electrophoresis —A small blood sample is taken and sent to a laboratory, where the percentage of normal and abnormal hemoglobin is measured.
Sickledex Test —A small blood sample is taken and sent to a laboratory. In the laboratory, a substance called a deoxygenating agent is added to the blood sample. If the deoxygenating agent causes at least 25% of the red blood cells to assume a sickle shape, the test is considered positive for the presence of either sickle cell trait or sickle cell disease. Hemoglobin electrophoresis will need to be done to distinguish between sickle cell trait and sickle cell disease.
Amniocentesis —In this test, ultrasound is used to locate the fetus and a pocket of amniotic fluid (the fluid that surrounds the growing fetus). A long, thin needle is used to remove a small amount of amniotic fluid, which is sent to a laboratory for testing.
In many hospitals, screening tests are done on newborn babies before they leave the hospital. Screening tests may also be done on young adults who wish to determine whether or not they and/or their partner carry the sickle cell trait prior to beginning a family. Pregnant women can also choose to have their unborn babies tested for the presence of sickle cell trait or disease.
- Reviewer: Michael Woods, MD
- Review Date: 10/2012 -
- Update Date: 10/11/2012 -